Latest Schedule 13G passive stakes

NASDAQ
SRPT
Sarepta Therapeutics, INC
SCHEDULE: State Street Discloses Sarepta Therapeutics Stake
State Street Corporation and its affiliate SSGA Funds Management, Inc. have filed a Schedule 13G, reporting beneficial ownership of Sarepta Therapeutics Inc. common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.1% Stake in Sable Offshore Corp
State Street Corporation has disclosed beneficial ownership of 5.1% of Sable Offshore Corp's common stock as of June 30, 2026.
NYSE
SOC
Sable Offshore CORP
SCHEDULE: State Street Reports 5.1% Stake in Sable Offshore Corp
State Street Corporation has disclosed beneficial ownership of 5.1% of Sable Offshore Corp's common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports 5.2% Stake in S&T Bancorp
State Street Corporation has disclosed beneficial ownership of 5.2% of S&T Bancorp's common stock as of June 30, 2026.
NASDAQ
STBA
S&T Bancorp INC
SCHEDULE: State Street Reports 5.2% Stake in S&T Bancorp
State Street Corporation has disclosed beneficial ownership of 5.2% of S&T Bancorp's common stock as of June 30, 2026.
NASDAQ
KITT
Nauticus Robotics, INC
SCHEDULE: SZOP Opportunities Discloses 9.9% Stake in Nauticus Robotics
SZOP Opportunities I LLC and SZOP Opportunities Management LLC have jointly filed a Schedule 13G, reporting a beneficial ownership of 9.9% in Nauticus Robotics, Inc. common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Corp. Adjusts Roper Technologies Stake
State Street Corporation has updated its beneficial ownership filing for Roper Technologies Inc., reporting a significant holding of over 5.1 million shares.
NASDAQ
ROP
Roper Technologies INC
SCHEDULE: State Street Corp. Adjusts Roper Technologies Stake
State Street Corporation has updated its beneficial ownership filing for Roper Technologies Inc., reporting a significant holding of over 5.1 million shares.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.3% Stake in Replimune Group
State Street Corporation has reported beneficial ownership of 5.3% of Replimune Group Inc.'s common stock as of June 30, 2026.
NASDAQ
REPL
Replimune Group, INC
SCHEDULE: State Street Discloses 5.3% Stake in Replimune Group
State Street Corporation has reported beneficial ownership of 5.3% of Replimune Group Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Redwire Corp Stake
State Street Corporation and its affiliate SSGA Funds Management, Inc. have filed a Schedule 13G, reporting a combined beneficial ownership of 7.3% in Redwire Corp's common stock as of June 30, 2026.
NYSE
RDW
Redwire CORP
SCHEDULE: State Street Discloses Redwire Corp Stake
State Street Corporation and its affiliate SSGA Funds Management, Inc. have filed a Schedule 13G, reporting a combined beneficial ownership of 7.3% in Redwire Corp's common stock as of June 30, 2026.
NASDAQ
TASK
Taskus, INC
SCHEDULE: Dalton Investments Reports 11.77% Stake in TaskUs
Dalton Investments Inc. has disclosed a beneficial ownership of 4,302,805 shares, representing 11.77% of TaskUs, Inc.'s common stock as of July 31, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Stake in Red Cat Holdings
State Street Corporation and its affiliate SSGA Funds Management, Inc. have reported a combined beneficial ownership of 8.2% in Red Cat Holdings Inc. as of June 30, 2026.
NASDAQ
RCAT
Red Cat Holdings, INC
SCHEDULE: State Street Discloses Stake in Red Cat Holdings
State Street Corporation and its affiliate SSGA Funds Management, Inc. have reported a combined beneficial ownership of 8.2% in Red Cat Holdings Inc. as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Corp Discloses Recursion Pharmaceuticals Stake
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 6.6% of Recursion Pharmaceuticals Inc. common stock as of June 30, 2026.
NASDAQ
RXRX
Recursion Pharmaceuticals, INC
SCHEDULE: State Street Corp Discloses Recursion Pharmaceuticals Stake
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 6.6% of Recursion Pharmaceuticals Inc. common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Reports Stake in Qualcomm
State Street Corporation has updated its Schedule 13G filing to reflect its beneficial ownership of 5% of Qualcomm Inc.'s common stock as of June 30, 2026.
NASDAQ
QCOM
Qualcomm Inc/de
SCHEDULE: State Street Reports Stake in Qualcomm
State Street Corporation has updated its Schedule 13G filing to reflect its beneficial ownership of 5% of Qualcomm Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Corp. Discloses PTC Inc. Stake
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.6% of PTC Inc.'s common stock as of June 30, 2026.
NASDAQ
PTC
Ptc INC
SCHEDULE: State Street Corp. Discloses PTC Inc. Stake
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.6% of PTC Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Corp. Discloses Stake in Protagonist Therapeutics
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.2% of Protagonist Therapeutics Inc. common stock as of June 30, 2026.
NASDAQ
PTGX
Protagonist Therapeutics, INC
SCHEDULE: State Street Corp. Discloses Stake in Protagonist Therapeutics
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.2% of Protagonist Therapeutics Inc. common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Corp. Discloses Stake in Preferred Bank
State Street Corporation has reported beneficial ownership of 5.5% of Preferred Bank's common stock, totaling 646,206 shares, as of June 30, 2026.
NASDAQ
PFBC
Preferred Bank
SCHEDULE: State Street Corp. Discloses Stake in Preferred Bank
State Street Corporation has reported beneficial ownership of 5.5% of Preferred Bank's common stock, totaling 646,206 shares, as of June 30, 2026.
NYSE
PPG
Ppg Industries INC
SCHEDULE: State Street Discloses 6.2% Stake in PPG Industries
State Street Corporation has reported beneficial ownership of 13,883,511 shares, representing 6.2% of PPG Industries' common stock, as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 6.2% Stake in PPG Industries
State Street Corporation has reported beneficial ownership of 13,883,511 shares, representing 6.2% of PPG Industries' common stock, as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Stake in Perspective Therapeutics
State Street Corporation has reported beneficial ownership of 5.3% of Perspective Therapeutics Inc.'s common stock as of June 30, 2026.
AMEX
CATX
Perspective Therapeutics, INC
SCHEDULE: State Street Discloses Stake in Perspective Therapeutics
State Street Corporation has reported beneficial ownership of 5.3% of Perspective Therapeutics Inc.'s common stock as of June 30, 2026.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses Peabody Energy Stake
State Street Corporation and its affiliate SSGA Funds Management, Inc. have updated their Schedule 13G filing, reporting a combined beneficial ownership of 9.1% in Peabody Energy Corp. as of June 30, 2026.